U.S. markets open in 3 hours 24 minutes

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7700-0.0300 (-1.67%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 6/18/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.16
52-Week Change 3-14.90%
S&P500 52-Week Change 333.63%
52 Week High 34.2100
52 Week Low 31.4200
50-Day Moving Average 31.8319
200-Day Moving Average 32.3735

Share Statistics

Avg Vol (3 month) 3492.6k
Avg Vol (10 day) 3361.7k
Shares Outstanding 539.65M
Implied Shares Outstanding 6N/A
Float 20.48M
% Held by Insiders 127.77%
% Held by Institutions 119.96%
Shares Short (May 27, 2021) 456.37k
Short Ratio (May 27, 2021) 40.07
Short % of Float (May 27, 2021) 4N/A
Short % of Shares Outstanding (May 27, 2021) 40.15%
Shares Short (prior month Apr 29, 2021) 4228.39k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Sep 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-101.26%
Return on Equity (ttm)-363.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.07M
Net Income Avi to Common (ttm)-17.08M
Diluted EPS (ttm)-0.5410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.06M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.79
Book Value Per Share (mrq)0.24

Cash Flow Statement

Operating Cash Flow (ttm)-16.95M
Levered Free Cash Flow (ttm)-11.4M